Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

recordati rare diseases, inc. - pasireotide (unii: 98h1t17066) (pasireotide - unii:98h1t17066) - signifor is indicated for the treatment of adult patients with cushing's disease for whom pituitary surgery is not an option or has not been curative. none. risk summary the limited data with signifor in pregnant women are insufficient to inform a drug-associated risk for major birth defects and miscarriage. in embryo-fetal development studies in rabbits, findings indicating developmental delay were observed with subcutaneous administration of pasireotide during organogenesis at doses less than the exposure in humans at the highest recommended dose; maternal toxicity was not observed at this dose (see data) . the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2%-4% and 15%-20%, respectively. data animal data in embryo-fetal development studies in rats given 1, 5, and 10 mg/kg/day subcutaneously throughout org

Irska - engleski - HPRA (Health Products Regulatory Authority)

casen-recordati s.l. - sodium picosulfate; light magnesium oxide; citric acid anhydrous - powder for oral solution in sachet - 10,3.5,10.97 gram(s) - contact laxatives; sodium picosulfate, combinations

Irska - engleski - HPRA (Health Products Regulatory Authority)

casen-recordati s.l. - macrogol 4000 - powder for oral solution - 10 gram(s) - osmotically acting laxatives; macrogol - drugs for constipation. osmotically acting laxatives - symptomatic treatment of constipation in adults and children aged 8 years and above

Irska - engleski - HPRA (Health Products Regulatory Authority)

casen-recordati s.l. - sodium dihydrogen phosphate dihydrate; disodium phosphate dodecahydrate - rectal solution - 21.4/9.4 gram(s) - enemas; sodium phosphate

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

recordati rare diseases, inc. - succimer (unii: dx1u2629qe) (succimer - unii:dx1u2629qe) - succimer 100 mg - chemet is indicated for the treatment of lead poisoning in pediatric patients with blood lead levels above 45 mcg/dl. chemet is not indicated for prophylaxis of lead poisoning in a lead-containing environment; the use of chemet should always be accompanied by identification and removal of the source of the lead exposure. chemet should not be administered to patients with a history of allergy to the drug.

Irska - engleski - HPRA (Health Products Regulatory Authority)

casen-recordati s.l. - sodium picosulfate; magnesium oxide, light ; citric acid - oral solution - sodium picosulfate, combinations

Irska - engleski - HPRA (Health Products Regulatory Authority)

recordati industria chimica e farmaceutica spa - fenticonazole nitrate - vaginal capsule, soft - 200 milligram(s) - imidazole derivatives; fenticonazole

Irska - engleski - HPRA (Health Products Regulatory Authority)

recordati industria chimica e farmaceutica spa - fenticonazole nitrate - vaginal capsule, soft - 600 milligram(s) - imidazole derivatives; fenticonazole

Irska - engleski - HPRA (Health Products Regulatory Authority)

recordati rare diseases - human hemin - concentrate for solution for infusion - 25 milligram(s)/millilitre - other hem products; hematin

Irska - engleski - HPRA (Health Products Regulatory Authority)

recordati ireland limited - flavoxate hydrochloride - film-coated tablet - 200 milligram(s) - drugs for urinary frequency and incontinence; flavoxate